The DOI matches its Crossref record; 84 of the 84 references it cites were found in a registry or an index.
Diagnosis, management and screening of early localised prostate cancer.
Open accessAbstract
The incidence of prostate cancer is rising worldwide, caused mainly by demographic factors, particularly the increasingly elderly population and, more importantly, the increasing number of cases identified following prostate specific antigen (PSA) testing. It is commonly quoted that many more men die with prostate cancer than of it. Autopsy/post-mortem studies show that while a very high proportion of elderly men have histological evidence of the disease, a much smaller proportion develop clinically apparent cancer. The natural history of prostate cancer is poorly understood, but progression appears to be related to stage and grade of tumour. Prostate cancer can be diagnosed by digital rectal examination (DRE), serum PSA test, and/or transrectal ultrasound (TRUS), with confirmation by biopsy. Each test identifies a proportion of cancers, with higher rates of detection when they are used in combination. The tests are also used to determine which tumours are localised within the prostate and are, thus, potentially treatable. Unfortunately, clinical staging is unreliable, with approximately one half of all tumours upstaged following surgery. Three major treatment options are available for localised prostate cancer: radical prostatectomy, radical radiotherapy and conservative management (involving monitoring and treatment of symptoms). Although radical treatment rates are rising, good quality evidence concerning their comparative effectiveness and cost-effectiveness is lacking. Observational studies of highly selected patient groups suggests that there may be a slightly lower mortality rate following radical treatments compared with conservative management, but there has been very little research into treatment complications and quality of life of men after any of the treatments. In the past, investigations of prostate cancer were reserved largely for patients exhibiting symptoms, but the introduction of the PSA test has opened up the possibility of screening healthy men for the disease. Observational studies suggest that DRE and PSA, combined with TRUS and biopsy, can identify localised prostate cancer in 3-5% of men, although the tests do result in a number of false positives and negatives. Major questions remain concerning the natural history of the disease, potential costs (financial, social and psychological) of a screening programme, and the effectiveness and cost-effectiveness of treatments for localised disease. The lack of good quality data and the strength of these concerns means that population screening for prostate cancer cannot be recommended.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for the Economic Evaluation of Health Care Programmes
Drummond, M. E., Sculpher, M. J., Torrance, G. W., O’Brien, B. J., & Stoddart, G. L. (2005) · doi:10.1093/oso/9780198529446.001.0001 · Cited by 13,648
Methods for the economic evaluation of health care programmes
Wilson, S. H. (1987) · Journal of Epidemiology and Community Health · doi:10.1136/jech.41.4.355-a · Cited by 4,275
Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer
Catalona, W. J., Smith, D. S., Ratliff, T. L., Dodds, K. M., Coplen, D. E., Yuan, J. J. J., Petros, J. A., & Andriole, G. L. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104253241702 · Cited by 2,361
Catalona, W. J., Richie, J. P., Ahmann, F. R., Hudson, M. A., Scardino, P. T., Flanigan, R. C., Dekernion, J. B., Ratliff, T. L., Kavoussi, L. R., Dalkin, B. L., et al. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)35233-3 · Cited by 1,592
Random Systematic Versus Directed Ultrasound Guided Transrectal Core Biopsies of the Prostate
Hodge, K. K., McNeal, J. E., Terris, M. K., & Stamey, T. A. (1989) · Journal of Urology · doi:10.1016/s0022-5347(17)38664-0 · Cited by 1,571
Principles and Practice of Screening for Disease.
Zavon, M. R. (1969) · Archives of Internal Medicine · doi:10.1001/archinte.1969.00300130131020 · Cited by 1,356
Partin, A. W., Yoo, J., Carter, H. B., Pearson, J. D., Chan, D. W., Epstein, J. I., & Walsh, P. C. (1993) · Journal of Urology · doi:10.1016/s0022-5347(17)35410-1 · Cited by 1,278
Longitudinal Evaluation of Prostate-Specific Antigen Levels in Men With and Without Prostate Disease
Carter, H. B. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480160073037 · Cited by 1,096
Catalona, W. J. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510080052031 · Cited by 998
Results of Conservative Management of Clinically Localized Prostate Cancer
Chodak, G. W., Thisted, R. A., Gerber, G. S., Johansson, J.-E., Adolfsson, J., Jones, G. W., Chisholm, G. D., Moskovitz, B., Livne, P. M., & Warner, J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401273300403 · Cited by 928
Oesterling, J. E. (1993) · JAMA · doi:10.1001/jama.1993.03510070082041 · Cited by 807
Cooner, W. H., Mosley, B. R., Rutherford, C. L., Beard, J. H., Pond, H. S., Terry, W. J., Igel, T. C., & Kidd, D. D. (1990) · Journal of Urology · doi:10.1016/s0022-5347(17)40211-4 · Cited by 767
Walsh, P. C., Partin, A. W., & Epstein, J. I. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)32396-0 · Cited by 681
Zincke, H., Oesterling, J. E., Blute, M. L., Bergstralh, E. J., Myers, R. P., & Barrett, D. M. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)32399-6 · Cited by 672
Patient-re ported complications and follow-up treatment after radical prostatectomy
Fowler, F. J., Barry, M. J., Lu-yao, G., Roman, A., Wasson, J., & Wennberg, J. E. (1993) · Urology · doi:10.1016/0090-4295(93)90524-e · Cited by 627
Hereditary Prostate Cancer: Epidemiologic and Clinical Features
Carter, B. S., Bova, G. S., Beaty, T. H., Steinberg, G. D., Childs, B., Isaacs, W. B., & Walsh, P. C. (1993) · Journal of Urology · doi:10.1016/s0022-5347(17)35617-3 · Cited by 612
PATTERNS OF PROGRESSION IN PROSTATE CANCER
Mcneal, J., Kindrachuk, R., Freiha, F., Bostwick, D., Redwine, E., & Stamey, T. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90715-4 · Cited by 582
Latent carcinoma of the prostate
Franks, L. M. (1954) · The Journal of Pathology and Bacteriology · doi:10.1002/path.1700680233 · Cited by 528
Sexual Function following Radical Prostatectomy: Influence of Preservation of Neurovascular Bundles
Quinlan, D. M., Epstein, J. I., Carter, B. S., & Walsh, P. C. (1991) · Journal of Urology · doi:10.1016/s0022-5347(17)38512-9 · Cited by 510
Determination of Prostate Volume by Transrectal Ultrasound
Terris, M. K., & Stamey, T. A. (1991) · Journal of Urology · doi:10.1016/s0022-5347(17)38508-7 · Cited by 491
Risk Factors for Prostate Cancer
Pienta, K. J., & Esper, P. S. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-10-199305150-00007 · Cited by 490
High 10-Year Survival Rate in Patients With Early, Untreated Prostatic Cancer
Johansson, J.-E. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480160049033 · Cited by 467
Cancer in the European community and its member states
Møller Jensen, O., Estève, J., Møller, H., & Renard, H. (1990) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(90)90278-2 · Cited by 455
Ultrasound Guided Transrectal Core Biopsies of the Palpably Abnormal Prostate
Hodge, K. K., McNeal, J. E., & Stamey, T. A. (1989) · Journal of Urology · doi:10.1016/s0022-5347(17)38663-9 · Cited by 428
Return of Erections and Urinary Continence Following Nerve Sparing Radical Retropubic Prostatectomy
Catalona, W. J., & Basler, J. W. (1993) · Journal of Urology · doi:10.1016/s0022-5347(17)35645-8 · Cited by 357
Prospective Study of Plasma Fatty Acids and Risk of Prostate Cancer
Gann, P. H., Hennekens, C. H., Sacks, F. M., Grodstein, F., Giovannucci, E. L., & Stampfer, M. J. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.4.281 · Cited by 356
Stage, Age, Comorbidity, and Direct Costs of Colon, Prostate, and Breast Cancer Care
Taplin, S. H., Barlow, W., Urban, N., Mandelson, M. T., Timlin, D. J., Ichikawa, L., & Nefcy, P. (1995) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/87.6.417 · Cited by 344
Serum Prostate Specific Antigen as Pre-Screening Test for Prostate Cancer
Labrie, F., Dupont, A., Suburu, R., Cusan, L., Tremblay, M., Gomez, J.-L., & Emond, J. (1992) · Journal of Urology · doi:10.1016/s0022-5347(17)37402-5 · Cited by 337
Prostate Cancer Screening: What We Know and What We Need To Know
Kramer, B. S., Brown, M. L., Prorok, P. C., Potosky, A. L., & Gohagan, J. K. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-9-199311010-00009 · Cited by 273
Leandri, P., Rossignol, G., Gautier, J.-R., & Ramon, J. (1992) · Journal of Urology · doi:10.1016/s0022-5347(17)37412-8 · Cited by 261
Radical Prostatectomy for Clinical Stage T1-2N0M0 Prostatic Adenocarcinoma: Long-Term Results
Paulson, D. F., Moul, J. W., & Walther, P. J. (1990) · Journal of Urology · doi:10.1016/s0022-5347(17)39686-6 · Cited by 261
Rosen, M. A., Goldstone, L., Lapin, S., Wheeler, T., & Scardino, P. T. (1992) · Journal of Urology · doi:10.1016/s0022-5347(17)36587-4 · Cited by 249
Changes in prostate cancer incidence and treatment in USA
Lu-Yao, G. L., & Greenberg, E. R. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91109-6 · Cited by 248
Prostatic carcinoma: staging by clinical assessment, CT, and MR imaging.
Hricak, H., Dooms, G. C., Jeffrey, R. B., Avallone, A., Jacobs, D., Benton, W. K., Narayan, P., & Tanagho, E. A. (1987) · Radiology · doi:10.1148/radiology.162.2.3797645 · Cited by 245
Frazier, H. A., Robertson, J. E., Humphrey, P. A., et al. (1993) · The Journal of Urology · doi:10.1016/s0022-5347(17)36132-3 · Cited by 217
Familial Patterns of Prostate Cancer: A Case-Control Analysis
Spitz, M. R., Currier, R. D., Fueger, J. J., Babaian, R. J., & Newell, G. R. (1991) · Journal of Urology · doi:10.1016/s0022-5347(17)38074-6 · Cited by 215
Report on a workshop of the UICC project on evaluation of screening for cancer
Miller, A. B., Chamberlain, J., Day, N. E., Hakama, M., & Prorok, P. C. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910460502 · Cited by 211
Gohagan, J. K., Prorok, P. C., Kramer, B. S., & Cornett, J. E. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)32412-6 · Cited by 210
Geographic, age, and racial variation in the treatment of local/regional carcinoma of the prostate.
Harlan, L., Brawley, O., Pommerenke, F., Wali, P., & Kramer, B. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.1.93 · Cited by 200
Screening for Prostate Cancer: A Decision Analytic View
Krahn, M. D. (1994) · JAMA · doi:10.1001/jama.1994.03520100035030 · Cited by 199
A Retrospective Cohort Study of Vasectomy and Prostate Cancer in US Men
Giovannucci, E. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500070058029 · Cited by 198
Rate of Change in Serum Prostate Specific Antigen Levels as a Method For Prostate Cancer Detection
Smith, D. S., & Catalona, W. J. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)32528-4 · Cited by 191
Quality of Life of Incontinent Men after Radical Prostatectomy
Herr, H. W. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)35038-3 · Cited by 186
Wolf, J. S., Cher, M. L., Dall’Era, M., Presti, J. C., Hricak, H., & Carroll, P. R. (1995) · PubMed · Cited by 181
Lee, F., Torp-Pedersen, S., Littrup, P. J., McLeary, R. D., McHugh, T. A., Smid, A. P., Stella, P. J., & Borlaza, G. S. (1989) · Radiology · doi:10.1148/radiology.170.1.2462262 · Cited by 180
Terris, M. K., McNeal, J. E., & Stamey, T. A. (1992) · Journal of Urology · doi:10.1016/s0022-5347(17)36735-6 · Cited by 178
Prostate-specific antigen in milk of lactating women
Yu, H., & Diamandis, E. P. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.1.54 · Cited by 176
Chan, D. W., Bruzek, D. J., Oesterling, J. E., Rock, R. C., & Walsh, P. C. (1987) · Clinical Chemistry · doi:10.1093/clinchem/33.10.1916 · Cited by 171
Economics of Screening for Carcinoma of the Prostate
Optenberg, S. A., & Thompson, I. M. (1990) · Urologic Clinics of North America · doi:10.1016/s0094-0143(21)01367-7 · Cited by 139
Assessing the Effectiveness of Community Screening Programs
Cadman, D. T. (1984) · JAMA · doi:10.1001/jama.1984.03340360046028 · Cited by 139
Kramer, B. S., Gohagan, J. K., Prorok, P. C., & Smart, C. R. (2010) · Cancer · doi:10.1002/cncr.2820710215 · Cited by 139
Radical Prostatectomy: the Pros and Cons of the Perineal Versus Retropubic Approach
Frazier, H. A., Robertson, J. E., & Paulson, D. F. (1992) · The Journal of Urology · doi:10.1016/s0022-5347(17)37413-x · Cited by 139
Sequelae of radical prostatectomy
Jønler, M., Messing, E. M., Rhodes, P. R., & Bruskewitz, R. C. (1994) · British Journal of Urology · doi:10.1111/j.1464-410x.1994.tb16626.x · Cited by 120
Lidbrink, E. K., Elfving, J., Frisell, J., & Jonsson, E. L. (1996) · BMJ · doi:10.1136/bmj.312.7026.273 · Cited by 119
Epidemiology of Prostate Cancer
Meikle, A. W., & Smith, J. A. J. (1990) · Urologic Clinics of North America · doi:10.1016/s0094-0143(21)01366-5 · Cited by 108
Evaluation of the Abbott IMx® Automated Immunoassay of Prostate-Specific Antigen
Vessella, R. L., Noteboom, J. L., & Lange, P. H. (1992) · Clinical Chemistry · doi:10.1093/clinchem/38.10.2044 · Cited by 107
A Critique of the Decision Analysis for Clinically Localized Prostate Cancer
Beck, J. R., Kattan, M. W., & Miles, B. J. (1994) · The Journal of Urology · doi:10.1016/s0022-5347(17)32409-6 · Cited by 102
Cancer of the Prostate: Epidemiology and Aetiology
Zaridze, D. G., & Boyle, P. (1987) · British Journal of Urology · doi:10.1111/j.1464-410x.1987.tb04862.x · Cited by 101
Prostate cancer: to screen or not to screen?
Schröder, F. H. (1993) · BMJ · doi:10.1136/bmj.306.6875.407 · Cited by 100
Narayan, P. A., Fournier, G. R., Gajendran, V., Leidich, R. B., Lo, R., Wolf, J. S., Jacob, G., Nicolaisen, G. S., Palmer, K., & Freina, F. (1994) · Urology · doi:10.1016/s0090-4295(94)80050-2 · Cited by 99
Psychological reactions in men screened for prostate cancer
Gustafsson, O., Theorell, T., Norming, U., Perski, A., Öhström, M., & Nyman, C. R. (1995) · British Journal of Urology · doi:10.1111/j.1464-410x.1995.tb07422.x · Cited by 88
Analysis of variation in prostate-specific antigen values
Riehmann, M., Rhodes, P. R., Cook, T. D., Grose, G. S., & Bruskewitz, R. C. (1993) · Urology · doi:10.1016/0090-4295(93)90364-g · Cited by 85
Quality of Life after Radical Retropubic Prostatectomy for Carcinoma of the Prostate
Pedersen, K. V., Carlsson, P., Rahmquist, M., & Varenhorst, E. (1993) · European Urology · doi:10.1159/000474254 · Cited by 80
The epidemiology of mass breast cancer screening—A plea for a valid measure of benefit
Schmidt, J. G. (1990) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(90)90002-7 · Cited by 77
Risk Factors for Perineal Seeding of Prostate Cancer after Needle Biopsy
Moul, J. W., Miles, B. J., Skoog, S. J., & McLeod, D. G. (1989) · The Journal of Urology · doi:10.1016/s0022-5347(17)38668-8 · Cited by 73
Progress and problems in screening for carcinoma of the prostate
Chodak, G. W., & Schoenberg, H. W. (1989) · World Journal of Surgery · doi:10.1007/bf01671155 · Cited by 71
Mettlin, C. J., Murphy, G. P., & Menck, H. R. (1994) · Urology · doi:10.1016/0090-4295(94)90236-4 · Cited by 64
Ultrasound-guided prostate biopsy Biopty gun superior to aspiration
Ragde, H., Aldape, H. C., & Bagley, C. M. (1988) · Urology · doi:10.1016/s0090-4295(98)90029-2 · Cited by 60
Prostate cancer screening: a decision analysis.
Cantor, S. B., Spann, S. J., Volk, R. J., Cardenas, M., & Warren, M. M. (1995) · PubMed · Cited by 59
Pilot study of screening for prostate cancer in general practice
Kemple, T., Chadwick, D. J., Gillatt, D. A., Abrams, P., Gingell, J. C., Astley, J. P., & MacIver, A. G. (1991) · The Lancet · doi:10.1016/0140-6736(91)90615-v · Cited by 58
Measurement of Serum Prostate Specific Antigen Using Imx Prostate Specific Antigen Assay
Klee, G. G., Dodge, L. A., Zincke, H., & Oesterling, J. E. (1994) · The Journal of Urology · doi:10.1016/s0022-5347(17)34879-6 · Cited by 58
The Role of Watchful Waiting In The Management of Localized Prostate Cancer
Chodak, G. W. (1994) · The Journal of Urology · doi:10.1016/s0022-5347(17)32381-9 · Cited by 56
Screening for prostate cancer—Necessity or nonsense?
Schröder, F. H., & Boyle, P. (1993) · European Journal of Cancer · doi:10.1016/s0959-8049(05)80339-9 · Cited by 52
Matzkin, H., & Soloway, M. S. (1993) · The Prostate · doi:10.1002/pros.2990220402 · Cited by 50
Morenas, A. D. L., Siroky, M. B., Merriam, J. C., & Stilmant, M. M. (1988) · Human Pathology · doi:10.1016/s0046-8177(88)80211-9 · Cited by 49
Screening for carcinoma of the prostate: a GP based study
Kirby, R. S., Kirby, M., Feneley, M. R., McNicholas, T., Mclean, A., & Webb, J. A. W. (1994) · British Journal of Urology · doi:10.1111/j.1464-410x.1994.tb16549.x · Cited by 27
Jonsson, P. M., Danneskiold-Samsøe, B., Heggestad, T., Iversen, P., & LEISTI, S. (1995) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300005262 · Cited by 16
PSA leads the way for detecting and following prostate cancer.
Oesterling, J. E. (1993) · PubMed · Cited by 12
Prostate‐specific antigen and prostate volume: A meta‐analysis of prostate cancer screening criteria
Aziz, D. C., & Barathur, R. B. (1993) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.1860070509 · Cited by 9
Prostate-specific antigen in a community screening program.
Schwartz, K., Kau, T. Y., Severson, R. K., et al. (1995) · PubMed · Cited by 9
Treatment of Localized Prostate Cancer
Stephenson, A. J. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-900-6_14 · Cited by 4
Ep, E. (1995) · PubMed · Cited by 3
Mor, Y., Shenfeld, O. Z., Leibovich, I., Raviv, G., Nativ, O., & Goldwasser, B. (1995) · PubMed · Cited by 3
Cancer Epidemiology In Australia: Priorities For The 1990S And Beyond
Giles, G. G. (1992) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1992.tb121448.x · Cited by 3
Cited by
Evaluating non-randomised intervention studies
Deeks, J., Dinnes, J., D'Amico, R., Sowden, A., Sakarovitch, C., Song, F., Petticrew, M., & Altman, D. (2003) · Health Technology Assessment · doi:10.3310/hta7270 · Cited by 2,907
Donovan, J., Little, P., Mills, N., Smith, M., Brindle, L., Jacoby, A., Peters, T., Frankel, S., Neal, D., & Hamdy, F. (2002) · BMJ · doi:10.1136/bmj.325.7367.766 · Cited by 533
Eichler, K., Hempel, S., Wilby, J., Myers, L., Bachmann, L. M., & Kleijnen, J. (2006) · Journal of Urology · doi:10.1016/s0022-5347(05)00957-2 · Cited by 518
Quinn, M., & Babb, P. (2002) · BJU International · doi:10.1046/j.1464-410x.2002.2822.x · Cited by 446
Dinnes, J., Deeks, J., Kirby, J., & Roderick, P. (2005) · Health Technology Assessment · doi:10.3310/hta9120 · Cited by 438
Metadata
- Authors
- Selley, Donovan, Faulkner, Coast, & Gillatt
- Venue
- Health Technology Assessment
- Published
- 1997
- Volume
- 1
- Issue
- 2
- Pages
- i, 1-96
- ISSN
- 1366-5278 (ISSN-L)
- 2046-4924
- OpenAlex
- W3142152021
- Cited by
- 277
- References
- 84
- FWCI
- 12.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.